Rational design of innate defense regulator peptides as tumor vaccine adjuvants
Abstract The development of adjuvants has been an empirical process. Efforts to develop a new design and evaluation system for novel adjuvants are not only desirable but also necessary. Moreover, composite adjuvants that contain two or more types of adjuvants to synergistically enhance the immune re...
Guardado en:
Autores principales: | Yaomei Tian, Qiuyue Hu, Rui Zhang, Bailing Zhou, Daoyuan Xie, Yuanda Wang, Xueyan Zhang, Li Yang |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/e782e8939a9043a99db29cbb390a8f0f |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Rationally Designed TLR4 Ligands for Vaccine Adjuvant Discovery
por: Kelsey A. Gregg, et al.
Publicado: (2017) -
Cholesterol modified DP7 and pantothenic acid induce dendritic cell homing to enhance the efficacy of dendritic cell vaccines
por: Rui Zhang, et al.
Publicado: (2021) -
Aminated nanomicelles as a designer vaccine adjuvant to trigger inflammasomes and multiple arms of the innate immune response in lymph nodes
por: Song C, et al.
Publicado: (2017) -
Deimmunization of flagellin for repeated administration as a vaccine adjuvant
por: Koemchhoy Khim, et al.
Publicado: (2021) -
Rational design of hyperstable antibacterial peptides for food preservation
por: Yashavantha L. Vishweshwaraiah, et al.
Publicado: (2021)